GLOW Blend Pen 70mg (GHK-Cu • BPC-157 • TB-500) Premixed Prefilled

• One pre-configured research delivery device containing a total peptide content of 70 mg:

  • GHK-Cu (Copper Tripeptide): 50 mg

  • BPC-157: 10 mg

  • TB-500 (Thymosin Beta-4 fragment): 10 mg

• Secure, sealed laboratory packaging

• Batch-specific verification documentation

• Multi-peptide formulation supplied in a pre-standardised research solution

• Designed to support repeatable and consistent laboratory conditions

• Batch-verified for identity, purity, and formulation consistency

• Suitable for in-vitro, analytical, and comparative research models

• Research-grade production and sterile packaging standards

• Reduces preparation variability during experimental setup

This research delivery system incorporates a 0–60 graduated measurement scale designed to support laboratory documentation and proportional reference tracking during analytical and in-vitro research workflows.

Each 0–60 scale segment represents approximately 25% of the total solution volume contained within the device. The scale is provided to assist researchers in recording relative allocation during controlled experimental procedures and does not represent administration or application guidance.

Total peptide content per device (100%):

• GHK-Cu: 50 mg

• BPC-157: 10 mg

• TB-500: 10 mg

Approximate peptide content per 0–60 scale segment (~25% of total):

• GHK-Cu: ~12.5 mg

• BPC-157: ~2.5 mg

• TB-500: ~2.5 mg

Proportional reference examples within a single 0–60 segment:

• 30 on the scale (~50% of the segment / ~12.5% of total):

  • GHK-Cu: ~6.25 mg

  • BPC-157: ~1.25 mg

  • TB-500: ~1.25 mg

• 20 on the scale (~33% of the segment / ~8.3% of total):

  • GHK-Cu: ~4.1 mg

  • BPC-157: ~0.8 mg

  • TB-500: ~0.8 mg

All values are approximate and provided solely as proportional reference data to support laboratory record-keeping, analytical comparison, and experimental reproducibility.
They do not constitute instructions for use, administration, or application.

This multi-peptide system is examined within controlled laboratory and in-vitro research environments, including but not limited to:

• Peptide-mediated cellular signalling and communication pathways

• Extracellular matrix interaction and structural biology studies

• Cytoprotective and angiogenic signalling pathway investigation

• Comparative and synergistic peptide interaction analysis

• Peptide stability and formulation behaviour under laboratory conditions

This delivery format supports observation of multi-pathway peptide interactions within a consistent solution matrix designed exclusively for non-clinical research applications.
No therapeutic, cosmetic, or personal use is stated or implied.

• Store at 2–8 °C

• Protect from heat, moisture, and direct light

• Keep sealed until laboratory analysis

• Dispose of materials according to laboratory safety protocols